Weekly Intelligence · 6 articles
Vet Industry Intel: Feb 22 – Feb 28, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Acquisitions & M&A
Covetrus and MWI Animal Health agree to merge in $3.5 billion deal
Covetrus and MWI Animal Health have agreed to merge in a $3.5 billion deal, as reported by DVM360.
Covetrus · MWI Animal Health · DVM360
Regulatory & Policy
FDA approves first and only second-generation Janus kinase inhibitor
The FDA has approved the first and only second-generation Janus kinase inhibitor for veterinary use, according to reports by DVM360.
FDA · DVM360
FDA issues Emergency Use Authorizations for NWS meds for dogs, cats
The FDA has issued Emergency Use Authorizations for New World Screwworm (NWS) medications for dogs and cats.
FDA · Veterinary Practice News
Products & Technology
Wrap up: Merck Animal Health’s atinvicitinib tablets receive FDA approval, and other news
Merck Animal Health received FDA approval for its atinvicitinib tablets, as highlighted in veterinary industry news.
Merck Animal Health · FDA · DVM360
FDA Approves NUMELVI from Merck Animal Health for the Control of Pruritus in Dogs
The FDA approved NUMELVI from Merck Animal Health for the control of pruritus in dogs.
Merck Animal Health · FDA · Pet Age
Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics
Gallant has partnered with MWI Animal Health to distribute its anticipated FDA-conditionally approved stem cell therapy directly to veterinary clinics.
Gallant · MWI Animal Health